![](/img/cover-not-exists.png)
666TiPA phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL)
Saunders, M P, Graham, J, Cunningham, D, Plummer, R, Cook, S, Church, D, Kerr, R, Thangue, N La, Kerr, D JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz246.143
Date:
October, 2019
File:
PDF, 81 KB
2019